DR. W. VERHOEVEN,huisarts
0823.684.408 · rovalta.com · 26/09/2026
NORMAL SITUATION
DR. W. VERHOEVEN,huisarts
Company — Normal situation.
Financial year 2024 · Closed on 18/04/2024
Net result4,2 k €-94,9 %over 1 year
Gross margin-1,4 k €-101,2 %over 1 year
Equity875,9 k €+0,5 %over 1 year
Overview
Identity
Source · BCE/KBODR. W. VERHOEVEN,huisarts is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0823.684.408
- Legal form
- Private company with limited liability
- Contributed capital
- 12 500,00 €
- Latest accounts
- 18/04/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflow
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,4 k € | -101% | 122,4 k € | -4.8% | 128,7 k € | -14.1% | 149,8 k € | +28.1% | 116,9 k € |
| EBITDA | -2 k € | -102% | 116 k € | -9.7% | 128,5 k € | -14.2% | 149,7 k € | +28.2% | 116,8 k € |
| Operating result | -2 k € | -102% | 115,8 k € | -2.8% | 119,1 k € | -14.8% | 139,8 k € | +26.5% | 110,5 k € |
| Net result | 4,2 k € | -94.9% | 83,4 k € | -2.0% | 85,1 k € | -14.3% | 99,3 k € | +23.9% | 80,1 k € |
| Balance sheet | |||||||||
| Equity | 875,9 k € | +0.5% | 871,7 k € | +10.5% | 789,1 k € | +12.0% | 704,7 k € | +16.2% | 606,2 k € |
| Total assets | 950,5 k € | -0.0% | 950,6 k € | +7.2% | 886,7 k € | +11.4% | 795,9 k € | +15.3% | 690 k € |
| Cash | 943,1 k € | +820% | 102,5 k € | -87.5% | 820,1 k € | +10.3% | 743,2 k € | +19.3% | 623,1 k € |
| Debts | 74,6 k € | +0.8% | 74 k € | -23.4% | 96,6 k € | +9.3% | 88,4 k € | +11.5% | 79,3 k € |
Board of directors
Source · NBB, accounts to 18/04/20241 active · 3 ended
Active mandates
WERNER VERHOEVEN
ActiveEnded mandates
Werner VERHOEVEN
EndedWERNER VERHOEVEN
EndedWERNER VERHOEVEN
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 18/04/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 4 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/04/2024 | 26/03/2024 | 02/06/2023 | 23/06/2022 | 29/06/2021 | 30/06/2020 |
| General meeting | 18/04/2024 | 14/03/2024 | 01/06/2023 | 01/06/2022 | 01/06/2021 | 01/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 18/04/2024 | 18/04/2024 | 26/04/2024 | Dutch | |
| Micro model | 31/12/2023 | 14/03/2024 | 26/03/2024 | Dutch | |
| Micro model | 31/12/2022 | 01/06/2023 | 02/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 01/06/2022 | 23/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 01/06/2021 | 29/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 01/06/2020 | 30/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 01/06/2019 | 04/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 01/06/2018 | 29/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 01/06/2017 | 06/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 27/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 05/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 01/06/2014 | 01/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 01/06/2013 | 11/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 01/06/2012 | 06/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 01/06/2011 | 30/08/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 18/04/20241 active · 3 ended
Active mandates
WERNER VERHOEVEN
ActiveEnded mandates
Werner VERHOEVEN
EndedWERNER VERHOEVEN
EndedWERNER VERHOEVEN
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 20244,2 k €↓
- 2023Annual accounts 202383,4 k €↓
- 2023Name changeDR. W. VERHOEVEN, huisarts
- 2022Annual accounts 202285,1 k €↓
- 2022Name changeVerhoeven W. Dr.
- 2021Annual accounts 202199,3 k €↑
- 2021Name changeVERHOEVEN WERNER DR.
- 2020Annual accounts 202080,1 k €↓
- 2019Annual accounts 201989,4 k €↑
- 2018Annual accounts 201878,7 k €↑
- 2017Annual accounts 201774,1 k €↑
- 2016Annual accounts 201669 k €↑
- 2015Annual accounts 201563,3 k €↓
- 2014Annual accounts 201469 k €↑
- 2013Annual accounts 201366,4 k €↑
- 2012Annual accounts 201262,5 k €↑
- 2011Annual accounts 201151,3 k €↑
- 2010Annual accounts 201047,4 k €